Millipore Sigma Vibrant Logo

219467 Cathepsin V, His•Tag®, Human, Recombinant, NSO Cells

Cathepsin V, His•Tag®, is a recombinant human procathepsin V (aa 18-334) fused at the N-terminus to a CD33 signal sequence (aa 1-16) & at C-terminus to a His•Tag® sequence & expressed in NSO cells.

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Cathepsin L2, Cathepsin U

View Products on Sigmaaldrich.com
219467
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
219467-10UG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 10 μg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewRecombinant, human procathepsin V (amino acids 18-334) fused at the N-terminus to a CD33 signal sequence (amino acids 1-16) and at the C-terminus to a His•Tag® sequence and expressed in NSO cells. Cat V is predominantly expressed in normal thymus, testis, and corneal epithelium. It is involved in the invariant chain degradation in thymic epithelial cells and its overexpression has been detected in myasthenia gravis. Abnormally wide spread expressions in mammary gland and colon have also been reported in breast and colonrectal carcinomas. Although it shows high amino acid identity with cathepsin L (Cat. No. 219382), these two cathepsins have very different tissue distribution and substrate specificity. As a result of glycosylation, this recombinant enzyme migrates ~40 kDa on SDS-PAGE under either reducing or non-reducing conditions. Requires activation prior to use.
      Catalogue Number219467
      Brand Family Calbiochem®
      SynonymsCathepsin L2, Cathepsin U
      References
      ReferencesTolosa, E., et al. 2003. J. Clin. Invest. 112, 517.
      Turk, V., et al. 2001. EMBO J. 20, 4629.
      Somoza, J.R., et al. 2000. Biochemistry 39, 12543.
      Bromme, D., et al. 1999. Biochemistry 38, 2377.
      Adachi, W., et al. 1998. Invest. Ophthalmol. Vis. Sci. 39, 1789.
      Santamaria, I., et al. 1998. Cancer Res. 58, 1624.
      Product Information
      Unit of DefinitionOne unit is defined as the amount of enzyme that will cleave 1 pmol the fluorescent substrate Z-LR-AMC per min at 25°C, pH 5.5.
      EC number3.4.22.43
      FormFrozen liquid
      FormulationIn 800 mM NaCl, 25 mM sodium acetate, 0.8 M NaCl, pH 5.0.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      Specific Activity≥300 units/µg
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      ContaminantsEndotoxins: ≤1.0 EU/µg Cathepsin V
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsTo activate rhCathepsin V, pre-incubate it at 20 µg/ml in 25 mM NaOAc, 100 mM NaCl, 5 mM DTT, pH 5.5 at room temperature. Following initial thaw aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      219467-10UG 04055977218497

      Documentation

      Cathepsin V, His•Tag®, Human, Recombinant, NSO Cells FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Cathepsin V, His•Tag®, Human, Recombinant, NSO Cells Certificats d'analyse

      TitreNuméro de lot
      219467

      Références bibliographiques

      Aperçu de la référence bibliographique
      Tolosa, E., et al. 2003. J. Clin. Invest. 112, 517.
      Turk, V., et al. 2001. EMBO J. 20, 4629.
      Somoza, J.R., et al. 2000. Biochemistry 39, 12543.
      Bromme, D., et al. 1999. Biochemistry 38, 2377.
      Adachi, W., et al. 1998. Invest. Ophthalmol. Vis. Sci. 39, 1789.
      Santamaria, I., et al. 1998. Cancer Res. 58, 1624.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision27-November-2008 RFH
      SynonymsCathepsin L2, Cathepsin U
      DescriptionRecombinant, human procathepsin V (amino acids 18-334) fused at the N-terminus to a CD33 signal sequence (amino acids 1-16) and at the C-terminus to a His•Tag® sequence and expressed in NSO cells. Cat V is predominantly expressed in normal thymus, testis, and corneal epithelium. It is involved in the invariant chain degradation in thymic epithelial cells and its overexpression has been detected in myasthenia gravis. Abnormally wide spread expressions in mammary gland and colon have also been reported in breast and colonrectal carcinomas. Although it shows high amino acid identity with cathepsin L (Cat. No. 219382), these two cathepsins have very different tissue distribution and substrate specificity. As a result of glycosylation, this recombinant enzyme migrates ~40 kDa on SDS-PAGE under either reducing or non-reducing conditions. Requires activation prior to use.
      FormFrozen liquid
      FormulationIn 800 mM NaCl, 25 mM sodium acetate, 0.8 M NaCl, pH 5.0.
      Concentration Label Please refer to vial label for lot-specific concentration
      EC number3.4.22.43
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxins: ≤1.0 EU/µg Cathepsin V
      Specific activity≥300 units/µg
      Unit definitionOne unit is defined as the amount of enzyme that will cleave 1 pmol the fluorescent substrate Z-LR-AMC per min at 25°C, pH 5.5.
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsTo activate rhCathepsin V, pre-incubate it at 20 µg/ml in 25 mM NaOAc, 100 mM NaCl, 5 mM DTT, pH 5.5 at room temperature. Following initial thaw aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesTolosa, E., et al. 2003. J. Clin. Invest. 112, 517.
      Turk, V., et al. 2001. EMBO J. 20, 4629.
      Somoza, J.R., et al. 2000. Biochemistry 39, 12543.
      Bromme, D., et al. 1999. Biochemistry 38, 2377.
      Adachi, W., et al. 1998. Invest. Ophthalmol. Vis. Sci. 39, 1789.
      Santamaria, I., et al. 1998. Cancer Res. 58, 1624.